Contract facts
FederalEO 14398 is a federal award for 242-Network Contract Office 02 (36C242) held by Ino Therapeutics LLC. Estimated value —. Related solicitation 36C24222Q1053.
Incumbent footprint
Public recordIno Therapeutics LLC — $2.5M obligated across 84 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24223A0002?
36C24223A0002 (EO 14398) is a 242-Network Contract Office 02 (36C242) award with an estimated value of —, currently held by Ino Therapeutics LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C242-23-A-0002?
36C242-23-A-0002 is the dashed form of PIID 36C24223A0002 (EO 14398), held by Ino Therapeutics LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24223A0002?
242-Network Contract Office 02 (36C242) awarded 36C24223A0002 to Ino Therapeutics LLC.
Who is the incumbent on 36C24223A0002?
Ino Therapeutics LLC is the incumbent with $2.5M across 84 related awards in SCOUT’s public footprint.
When does Ino Therapeutics LLC’s 36C24223A0002 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.